Cargando…

Men with Sickle Cell Anemia and Priapism Exhibit Increased Hemolytic Rate, Decreased Red Blood Cell Deformability and Increased Red Blood Cell Aggregate Strength

OBJECTIVES: To investigate the association between priapism in men with sickle cell anemia (SCA) and hemorheological and hemolytical parameters. MATERIALS AND METHODS: Fifty-eight men with SCA (median age: 38 years) were included; 28 who had experienced priapism at least once during their life (pria...

Descripción completa

Detalles Bibliográficos
Autores principales: Cita, Kizzy-Clara, Brureau, Laurent, Lemonne, Nathalie, Billaud, Marie, Connes, Philippe, Ferdinand, Séverine, Tressières, Benoit, Tarer, Vanessa, Etienne-Julan, Maryse, Blanchet, Pascal, Elion, Jacques, Romana, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856257/
https://www.ncbi.nlm.nih.gov/pubmed/27145183
http://dx.doi.org/10.1371/journal.pone.0154866
_version_ 1782430475042684928
author Cita, Kizzy-Clara
Brureau, Laurent
Lemonne, Nathalie
Billaud, Marie
Connes, Philippe
Ferdinand, Séverine
Tressières, Benoit
Tarer, Vanessa
Etienne-Julan, Maryse
Blanchet, Pascal
Elion, Jacques
Romana, Marc
author_facet Cita, Kizzy-Clara
Brureau, Laurent
Lemonne, Nathalie
Billaud, Marie
Connes, Philippe
Ferdinand, Séverine
Tressières, Benoit
Tarer, Vanessa
Etienne-Julan, Maryse
Blanchet, Pascal
Elion, Jacques
Romana, Marc
author_sort Cita, Kizzy-Clara
collection PubMed
description OBJECTIVES: To investigate the association between priapism in men with sickle cell anemia (SCA) and hemorheological and hemolytical parameters. MATERIALS AND METHODS: Fifty-eight men with SCA (median age: 38 years) were included; 28 who had experienced priapism at least once during their life (priapism group) and 30 who never experienced this complication (control group). Twenty-two patients were treated with hydroxycarbamide, 11 in each group. All patients were at steady state at the time of inclusion. Hematological and biochemical parameters were obtained through routine procedures. The Laser-assisted Optical Rotational Cell Analyzer was used to measure red blood cell (RBC) deformability at 30 Pa (ektacytometry) and RBC aggregation properties (laser backscatter versus time). Blood viscosity was measured at a shear rate of 225 s(-1) using a cone/plate viscometer. A principal component analysis was performed on 4 hemolytic markers (i.e., lactate dehydrogenase (LDH), aspartate aminotransferase (ASAT), total bilirubin (BIL) levels and reticulocyte (RET) percentage) to calculate a hemolytic index. RESULTS: Compared to the control group, patients with priapism exhibited higher ASAT (p = 0.01), LDH (p = 0.03), RET (p = 0.03) levels and hemolytic indices (p = 0.02). Higher RBC aggregates strength (p = 0.01) and lower RBC deformability (p = 0.005) were observed in patients with priapism compared to controls. After removing the hydroxycarbamide-treated patients, RBC deformability (p = 0.01) and RBC aggregate strength (p = 0.03) were still different between the two groups, and patients with priapism exhibited significantly higher hemolytic indices (p = 0.01) than controls. CONCLUSION: Our results confirm that priapism in SCA is associated with higher hemolytic rates and show for the first time that this complication is also associated with higher RBC aggregate strength and lower RBC deformability.
format Online
Article
Text
id pubmed-4856257
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-48562572016-05-07 Men with Sickle Cell Anemia and Priapism Exhibit Increased Hemolytic Rate, Decreased Red Blood Cell Deformability and Increased Red Blood Cell Aggregate Strength Cita, Kizzy-Clara Brureau, Laurent Lemonne, Nathalie Billaud, Marie Connes, Philippe Ferdinand, Séverine Tressières, Benoit Tarer, Vanessa Etienne-Julan, Maryse Blanchet, Pascal Elion, Jacques Romana, Marc PLoS One Research Article OBJECTIVES: To investigate the association between priapism in men with sickle cell anemia (SCA) and hemorheological and hemolytical parameters. MATERIALS AND METHODS: Fifty-eight men with SCA (median age: 38 years) were included; 28 who had experienced priapism at least once during their life (priapism group) and 30 who never experienced this complication (control group). Twenty-two patients were treated with hydroxycarbamide, 11 in each group. All patients were at steady state at the time of inclusion. Hematological and biochemical parameters were obtained through routine procedures. The Laser-assisted Optical Rotational Cell Analyzer was used to measure red blood cell (RBC) deformability at 30 Pa (ektacytometry) and RBC aggregation properties (laser backscatter versus time). Blood viscosity was measured at a shear rate of 225 s(-1) using a cone/plate viscometer. A principal component analysis was performed on 4 hemolytic markers (i.e., lactate dehydrogenase (LDH), aspartate aminotransferase (ASAT), total bilirubin (BIL) levels and reticulocyte (RET) percentage) to calculate a hemolytic index. RESULTS: Compared to the control group, patients with priapism exhibited higher ASAT (p = 0.01), LDH (p = 0.03), RET (p = 0.03) levels and hemolytic indices (p = 0.02). Higher RBC aggregates strength (p = 0.01) and lower RBC deformability (p = 0.005) were observed in patients with priapism compared to controls. After removing the hydroxycarbamide-treated patients, RBC deformability (p = 0.01) and RBC aggregate strength (p = 0.03) were still different between the two groups, and patients with priapism exhibited significantly higher hemolytic indices (p = 0.01) than controls. CONCLUSION: Our results confirm that priapism in SCA is associated with higher hemolytic rates and show for the first time that this complication is also associated with higher RBC aggregate strength and lower RBC deformability. Public Library of Science 2016-05-04 /pmc/articles/PMC4856257/ /pubmed/27145183 http://dx.doi.org/10.1371/journal.pone.0154866 Text en © 2016 Cita et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Cita, Kizzy-Clara
Brureau, Laurent
Lemonne, Nathalie
Billaud, Marie
Connes, Philippe
Ferdinand, Séverine
Tressières, Benoit
Tarer, Vanessa
Etienne-Julan, Maryse
Blanchet, Pascal
Elion, Jacques
Romana, Marc
Men with Sickle Cell Anemia and Priapism Exhibit Increased Hemolytic Rate, Decreased Red Blood Cell Deformability and Increased Red Blood Cell Aggregate Strength
title Men with Sickle Cell Anemia and Priapism Exhibit Increased Hemolytic Rate, Decreased Red Blood Cell Deformability and Increased Red Blood Cell Aggregate Strength
title_full Men with Sickle Cell Anemia and Priapism Exhibit Increased Hemolytic Rate, Decreased Red Blood Cell Deformability and Increased Red Blood Cell Aggregate Strength
title_fullStr Men with Sickle Cell Anemia and Priapism Exhibit Increased Hemolytic Rate, Decreased Red Blood Cell Deformability and Increased Red Blood Cell Aggregate Strength
title_full_unstemmed Men with Sickle Cell Anemia and Priapism Exhibit Increased Hemolytic Rate, Decreased Red Blood Cell Deformability and Increased Red Blood Cell Aggregate Strength
title_short Men with Sickle Cell Anemia and Priapism Exhibit Increased Hemolytic Rate, Decreased Red Blood Cell Deformability and Increased Red Blood Cell Aggregate Strength
title_sort men with sickle cell anemia and priapism exhibit increased hemolytic rate, decreased red blood cell deformability and increased red blood cell aggregate strength
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856257/
https://www.ncbi.nlm.nih.gov/pubmed/27145183
http://dx.doi.org/10.1371/journal.pone.0154866
work_keys_str_mv AT citakizzyclara menwithsicklecellanemiaandpriapismexhibitincreasedhemolyticratedecreasedredbloodcelldeformabilityandincreasedredbloodcellaggregatestrength
AT brureaulaurent menwithsicklecellanemiaandpriapismexhibitincreasedhemolyticratedecreasedredbloodcelldeformabilityandincreasedredbloodcellaggregatestrength
AT lemonnenathalie menwithsicklecellanemiaandpriapismexhibitincreasedhemolyticratedecreasedredbloodcelldeformabilityandincreasedredbloodcellaggregatestrength
AT billaudmarie menwithsicklecellanemiaandpriapismexhibitincreasedhemolyticratedecreasedredbloodcelldeformabilityandincreasedredbloodcellaggregatestrength
AT connesphilippe menwithsicklecellanemiaandpriapismexhibitincreasedhemolyticratedecreasedredbloodcelldeformabilityandincreasedredbloodcellaggregatestrength
AT ferdinandseverine menwithsicklecellanemiaandpriapismexhibitincreasedhemolyticratedecreasedredbloodcelldeformabilityandincreasedredbloodcellaggregatestrength
AT tressieresbenoit menwithsicklecellanemiaandpriapismexhibitincreasedhemolyticratedecreasedredbloodcelldeformabilityandincreasedredbloodcellaggregatestrength
AT tarervanessa menwithsicklecellanemiaandpriapismexhibitincreasedhemolyticratedecreasedredbloodcelldeformabilityandincreasedredbloodcellaggregatestrength
AT etiennejulanmaryse menwithsicklecellanemiaandpriapismexhibitincreasedhemolyticratedecreasedredbloodcelldeformabilityandincreasedredbloodcellaggregatestrength
AT blanchetpascal menwithsicklecellanemiaandpriapismexhibitincreasedhemolyticratedecreasedredbloodcelldeformabilityandincreasedredbloodcellaggregatestrength
AT elionjacques menwithsicklecellanemiaandpriapismexhibitincreasedhemolyticratedecreasedredbloodcelldeformabilityandincreasedredbloodcellaggregatestrength
AT romanamarc menwithsicklecellanemiaandpriapismexhibitincreasedhemolyticratedecreasedredbloodcelldeformabilityandincreasedredbloodcellaggregatestrength